PetCaseFinder

Peer-reviewed veterinary case report

Tick-borne encephalitis virus infection in dogs and what it causes

By Salat, Jiri et al.·Published in Viruses·2021·Veterinary Research Institute·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Experimental and Natural Infections of Tick-Borne Encephalitis Virus in Dogs.

Species:
dog
Brain & nervesDogs

Plain-English summary

A group of three-month-old beagle puppies were infected with the tick-borne encephalitis virus (TBEV) to study its effects. Surprisingly, none of the puppies showed any noticeable symptoms or changes in their health, although a slight drop in certain blood cells was noted. The puppies did develop a strong immune response, producing antibodies against the virus. In a separate survey of dogs in an area where TBEV is common, about 13% of healthy dogs had antibodies indicating past exposure to the virus, but most showed no signs of illness. This suggests that while dogs can be exposed to TBEV, serious illness is rare.

People also search for: dog tick-borne encephalitis symptoms · beagle puppy immune response · TBEV exposure in dogs

Abstract

Dogs are frequently infected with the tick-borne encephalitis virus (TBEV). However, to date, only a few clinically manifest cases of tick-borne encephalitis (TBE) have been reported in dogs. In this study, three-month-old beagle dogs were infected with TBEV through a subcutaneous injection. Body temperature, clinical signs, blood haematology, blood biochemistry, and immune responses were monitored for up to 28 days postinfection (p.i.). No changes in body temperature or clinical signs were observed in the infected dogs. Most haematology and blood biochemistry parameters were unchanged after the infection, except for a slight reduction in blood lymphocyte counts, but they were within the physiological range. Low-titre viraemia was detected in 2/4 infected dogs between days 1 and 3 p.i. All infected dogs developed a robust immune response, in terms of neutralising antibodies. Thus, TBEV infections lead to effective seroconversion in dogs. Next, to assess TBEV exposure in dogs in the TBEV-endemic region of the Czech Republic, we conducted a serosurvey. Virus neutralisation tests revealed TBEV-specific antibodies in 17 of 130 (13.07%) healthy dogs, which confirmed a high, but clinically inappreciable TBEV exposure rate in the endemic area. The seropositivity rate was similar (12.7%; 41 positives out of 323) in a subgroup of dogs with various clinical disorders, and it was 13.4% (23 out of 171) in a subgroup of dogs with signs of acute neurological disease. Two dogs with fatal acute meningoencephalitis showed positive results for TBEV-specific IgM and IgG antibodies. These data extended our understanding of the clinical presentation of TBEV infections.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/34696468/